Work

Abstract 5237: The significant co-expression of claudin-3(CLDN3) and B7-H3(CD276) as a potential biomarker for targeted therapy in neuroendocrine carcinomas

Year: 2026
Type: conference-abstract
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W7148822722
Cites:
Cited by:
Related to: